
ãã¡ã€ã¶ãŒã²ãŒã: æ¿åºã®å ¬åŒå ±åã«ãããšãæ¯é±äœåäžäººãã®äººã ãCovid-19ã¯ã¯ãã³æ¥çš®ã®ããã«æ»äº¡ããŠããããšãæããã«
å èšäºã¯ãã¡ã/Original article here
çããã¯ãå»çå¶åºŠãå®ãããã«èªå®
ã§åŸ
æ©ããããã«æç€ºãããŸãããããããããããŠããéã«ããç
é¢ã¯å®è³ªçã«äŒæ¥ãéãããŠãããããã¯å
¬åŒããŒã¿ã«ãã£ãŠè£ä»ããããŠããŸããããªãã¯ãã¿ããªã®ç¥ãã«å¯ŸããçããšããŠãã³ãã19ã®æ³šå°ãåããããã«èšãããŸãããããããããªãããããå®è¡ããä»ãå»çå¶åºŠã¯åŽ©å£ã®å±æ©ã«çããŠããŸãã
ææ¥è»ã®åŸ
ã¡æéã¯é廿é«ãèšé²ããŠãããå¿åæ¢ã«ããææ¥åºåä»¶æ°ã¯é廿é«ã§ããæ»äº¡è
æ°ã¯é廿é«ã§ãæ¯é±ãäžçäžã§äœåäžäººãã®è¶
éæ»äº¡ãçºçããŠããã
ãããŠãæ¿åºã®å
¬åŒå ±åæžã¯ãããããã¹ãŠã³ãã€ã19ã¯ã¯ãã³ã®ãããã§ããããšãçãäœå°ããªã蚌æããŠããã
åºå±A: å»çå¶åºŠã«ç¡çããã
ã€ã³ã°ã©ã³ãã§ã¯ãè³åäžãå¿èçºäœã®çãã®ããæ£è ã®ããšã«ææ¥è»ãå°çãããŸã§ã«ãæå€§18åã®åŸ ã¡æéã®3å以äžã®1æéè¿ãããã£ãŠããããšããNHSã®ææ°ããŒã¿ããæããã«ãªããŸããã999ã«é»è©±ããŠããå¿ èŠãªææ¥å»çãåãããããã©ããããã¯ã確信ãæã€ããšã¯ã§ããŸããã
ãªãã§ããããïŒ
次ã®å³ã¯ãè±åœå¥åº·å®å šå±ã®ãAmbulance Syndromic Surveillance System - Week 30ãã®éå ±ããåŒçšãããã®ã§ãã€ã³ã°ã©ã³ãã«ãããå¿åæ¢ã®ããã«ææ¥è»ãèŠè«ãã999ã³ãŒã«ã®æ¥æ¬¡ä»¶æ°ãšäºæ³çïŒé»ãç¹ç·ïŒã瀺ããŠããŸãã

å°ãªããšã2021幎8æä»¥éã1æ¥ã®åºååæ°ã¯å¹³åã倧ããäžåã£ãŠããã
ãŸããåœæ°ä¿å¥ãµãŒãã¹ïŒNHSïŒã¯ãæ å ±å ¬éè«æ±ã«å¿ããŠãå¿èã«åœ±é¿ãåãŒãè¡°åŒ±ç¶æ ã«å¿ èŠãªç·æ¥ã®æ²»çã«é¢ããææ¥è»ã®åºåã2021å¹Žå šäœã§ã»ãŒ2åã«ãªãã2022幎ã«ãªã£ãŠãããã«å¢å åŸåã«ããããšã確èªããã
2022幎4æ25æ¥ããã³ã«ã³ã»ããºãã³ãã¯ããŠã§ã¹ãã»ãããã©ã³ãææ¥ãµãŒãã¹å€§åŠNHS財å£ãã©ã¹ãã«æ å ±å ¬éïŒFOIïŒè«æ±ãéãã2017幎1æ1æ¥ããçŸåšãŸã§ã®1幎ãããã®å¿èçŸæ£æ£è ã®åŒã³åºãåæ°ãç¥ãããèŠæ±ããã
NHSã¯5æ18æ¥ãèŠæ±ãããæ å ±ãå«ãã¹ãã¬ããã·ãŒãã§åçããŸããã
次ã®å³ã¯ãã¹ãã¬ããã·ãŒãã§å©çšå¯èœã«ãªã£ãããŒã¿ãèŠèŠåãããã®ã§ãã

髿¡ä»¶ã®ææ¥è»åŒåº-oursã¯ã2021幎1æä»¥éãå šäœçã«é«ããªããåææ¯ã§ãå¢å ããŠããŸãããããã30æ³æªæºã§å€§ããå¢å ããã®ã¯2021幎4æä»¥éã§ãåã³åææ¯ã§å¢å ããŠããŸãã
次ã®ã°ã©ãã¯ãå šå¡ãš0ïœ29æ³ã®å¹Žå¥ã®å šäœã®åºååæ°ã®æšç§»ã瀺ãããã®ã§ãã

2017幎ãã2020幎ã®å¹Žéå¹³ååºååæ°ã¯24,463åã«çžåœããã2021幎ã«48ïŒ å¢å ããåŒã³åºãã®æ°ãæå³ããã2017幎ãã2020幎ãŸã§ã®30代以äžã®å¹Žéå¹³ååºååæ°ã¯3,940åã«çžåœã2021幎ã®åºåä»¶æ°ã¯82ïŒ å¢å ããããšãæå³ããã
次ã®ã°ã©ãã¯ãå¿èã«é¢ããçç¶ã®ææ¥è»åºåä»¶æ°ã®æå¹³åã幎å¥ã«ç€ºãããã®ã§ãã

2021幎ã«ã¯ãã¹ãŠã®å¹Žéœ¢å±€ã§å€§å¹ ãªå¢å ãèŠãããŸããããæ®å¿µãªãã2022å¹Žã®æåã®æ°ã¶æã¯ããã«ç¶æ³ãæªåããŠããŸãã
åé¡ã¯ããªããïŒ
åºå žB: Covid-19 ã¯ã¯ãã³æ¥çš®ã¯å¿èã«ãã¡ãŒãžãäžãããããã¯äºå®ã§ãã
ã³ããã19ã®ã¯ã¯ãã³æ¥çš®ãå¿èã«æ·±å»ãªãã¡ãŒãžãäžããããšããçããªãç¥ãããããã«ãªã£ããšããäºå®ãèŠãŠã¿ãŸããããå¿ççãšå¿èçã¯ãå»çèŠå¶åœå±ãã³ããã-19ã¯ã¯ãã³æ¥çš®ã«ãã£ãŠèµ·ããããããšãèªããããåŸãªããªã£ãäžæ¡ãã®æå®³äºè±¡ã®ãã¡ã®2ã€ã«éããªãã®ã§ãã
圌ãã¯ãããã¯ãŸããªããšã ãšäž»åŒµããŠããããããã¯åã§ããã圌ããçºçãããããšãèªããããåŸãªãã£ããšããããšã¯ãäžè¬ã®äººã ãèããŠããããããã£ãšäžè¬çã§ãããšããããšã§ããã
ç±³åœçŸç 管çã»ã³ã¿ãŒãšé£åå»è¬åå±ã«ãã£ãŠã²ããã«è¡ãããç ç©¶ã«ãããšãmRNAã³ããã¯ã¯ãã³æ¥çš®åŸã®å¿ççã®ãªã¹ã¯ã¯ã人å£ã«ãããããã¯ã°ã©ãŠã³ããªã¹ã¯ãããçŽ133åã倧ããããšãå®éã«å€æããŠããŸãã

ã€ãŸããã³ããã¯ã¯ãã³æ¥çš®ã«ããå¿ççã«ããããªã¹ã¯ã13,200%ãšããè¡æçãªæ°åã«ãªãã®ã§ãã
å¿ççã¯ãå¿èã®çèã«ççãèµ·ãããå¿èãè¡æ¶²ãéãåºãèœåãäœäžããçŸæ£ã§ãå¿èã®ãªãºã ãéããªã£ãããç°åžžã«ãªã£ããããããšããããŸãã
æçµçã«å¿ççã¯å¿èã匱ãããäœã®ä»ã®éšåã«ååãªè¡æ¶²ãè¡ãæž¡ããªãããã«ããŸãããããŠãå¿èã«è¡æ ãã§ããè³åäžãå¿èçºäœãåŒãèµ·ããå¯èœæ§ããããŸãããã®ä»ã®å䜵çãšããŠãå¿èçªç¶æ»ããããŸãã
å¿ççã«ã¯è»œçã®ãã®ã¯ãªããå¿çãåçã§ããªãããæ¥µããŠæ·±å»ã§ãããããã£ãŠãäžåºŠãã¡ãŒãžãåãããšãæéãå·»ãæ»ãããšã¯ã§ããŸããã
以äžã®è¡šã¯ãç±³åœçŸç 管çã»ã³ã¿ãŒã®ã¯ã¯ãã³æå®³äºè±¡å ±åã·ã¹ãã ã«å ±åãããå¿ççã®å¹Žå¥å ±åã§ãã

ã€ã®ãªã¹ã§ã¯ãå¿èã«åœ±é¿ãåãŒãçŸæ£ã«é¢ããææ¥è»ã®åºåä»¶æ°ãé廿é«ãšãªã£ãŠããŸãããäžæè°ã§ã¯ãããŸãããïŒ
åºå žC:æ¯é±æ°åäžäººã®ãè¶ éæ»äº¡ããèšé²
åœå®¶çµ±èšå±ïŒONSïŒã¯ãã€ã³ã°ã©ã³ããšãŠã§ãŒã«ãºã§ç»é²ãããæ»äº¡è æ°ãæ¯é±çºè¡šããŠããŸããææ°ã®ããŒã¿ã§ã¯ã2022幎7æ29æ¥ãŸã§ã®æ»äº¡è æ°ã瀺ããŠããŸãã
ONSãäœæãã以äžã®ã°ã©ãã¯ã1é±éãããã®æ»äº¡è æ°ã5幎平åãšæ¯èŒãããã®ã§ãã

äžèšãããããããã«ã2021幎5æé ãããã€ã³ã°ã©ã³ããšãŠã§ãŒã«ãºã§ã¯ã5幎平åãšæ¯èŒããŠãCovid-19ã«èµ·å ããªãéå°æ»äº¡ã倧éã«èšé²ãããŠããŸãããã®åŸã2022幎ã®åãã«éå°æ»äº¡ãæžå°ããããã«èŠããã
ããããèŠããã«ããããæ»äº¡æ°ãæžå°ããã®ã¯ãONSã2021幎ã®ããŒã¿ã5幎平åã«å«ããããšã決å®ããããã§ããããã®ããã5幎平åïŒ2016幎ïœ2019幎ïŒ2021幎ïŒãšæ¯ã¹ãŠã2022幎4ææ«ããæ¯é±è¶ éæ»äº¡ãèšé²ããŠããããšãããäžå±€æ°ã«ãªãã
çŽè¿ã®1é±éã§ã¯ãã€ã³ã°ã©ã³ããšãŠã§ãŒã«ãºã§11,013äººã®æ»äº¡ãããã5幎平åã«å¯ŸããŠ1,678人ã®è¶ éæ»äº¡ã«çžåœããããšãããããŸãããã®ãã¡ãCovid-19ã«èµ·å ããæ»äº¡ã¯ããã810人ã§ããã

ãŠãŒãã¹ã¿ãããäœæãã2022幎5æã®æ¬§å·å šåã®è¶ éæ»äº¡çã瀺ã以äžã®å ¬åŒã°ã©ãã«èŠãããããã«ã欧å·ã®å€§éšåã§ãçžåœæ°ã®è¶ éæ»äº¡ãèšé²ããŠããŸã - ã

äžçã§ã¯ãæ¯é±ãæ³å®ãäžåãæ°äžããæ°åäžäººã®äººã ã亡ããªã£ãŠãããšããæ¥µããŠæ·±å»ãªåé¡ãèµ·ããŠããŸãã
ãããããããã®æ»äº¡ãã³ãã19ã®ã¯ã¯ãã³æ¥çš®ã«ãããã®ã§ãããšãã©ã®ããã«ããŠç¢ºå®çã«èšŒæã§ããã®ã§ããããããã®çãã¯ãã¯ã¯ãã³æ¥çš®è ãšéæ¥çš®è ã®10äžäººåœããã®å¹Žéœ¢æšæºåæ»äº¡çãæ¯èŒããããšã«ããã
åºå žD: ãã¹ãŠã®å¹Žéœ¢å±€ã§ã¯ã¯ãã³æªæ¥çš®è ã®æ»äº¡çãæãäœã
以äžã¯ãã³ãã19ã¯ã¯ãã³ãèŽåœçã§ãããäœå人ãã®äººã ãæ®ºããŠãããšããè°è«ã®äœå°ã®ãªã蚌æ ã§ããã
以äžã®ã°ã©ãã¯ã2022幎1æãã5æãŸã§ã®ã€ã³ã°ã©ã³ãã«ãããéã³ãã19ã®æ»äº¡ã«ã€ããŠãå幎霢局ã«ãããã¯ã¯ãã³æ¥çš®ç¶æ³å¥ã®æéœ¢æšæºåæ»äº¡çã瀺ããŠããããã®æ°åã¯ãè±åœæ¿åºæ©é¢ãåœå®¶çµ±èšå±ãæè¿å ¬è¡šããããŒã¿ã»ããã®è¡š2ã«ç€ºãããŠããã

2022幎ã«å ¥ã£ãŠãããã¹ãŠã®åæã§ãäžéšæ¥çš®ãšäºéæ¥çš®ã®18æ³ãã39æ³ã¯ãæªæ¥çš®ã®18æ³ãã39æ³ãããæ»äº¡çãé«ããªã£ãŠããŸãããããã3åæ¥çš®ã®18æ³ãã39æ³ã¯ã2021幎12æã«è±åœã§çºçããå€§èŠæš¡ãªBoosterãã£ã³ããŒã³ã®åŸãæããšã«æ»äº¡çãæªåããŠããŸãã

ãŸããä»ã®ãã¹ãŠã®å¹Žéœ¢å±€ã§ãåæ§ã®ãã¿ãŒã³ãèŠãããŸãã






ããã¯å¹Žéœ¢ã§æšæºåããæ°åã§ããã10äžäººåœããã®æ»äº¡çãã¯ã¯ãã³æªæ¥çš®è ã®éã§æãäœããšããäºå®ã¯ãã³ãã19ã®æ³šå°ã人ã ãæ®ºããŠãããšãã以å€ã«çµè«ã¯ãªãã ããã
ããããããã ãã§ã¯ã圌ã®ç Žæ» çãªäºå®ã«ç®ãèŠéãã«ã¯ååã§ã¯ãªãã®ã§ããã®äºå®ãè£ä»ããè°è«ã®äœå°ã®ãªã蚌æ ãããã«å¹Ÿã€ã玹ä»ãããã
åºå žEïŒã¯ã¯ãã³æ¥çš®è 246人ã«1人ãCovid-19ã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«æ»äº¡
è±åœæ¿åºã¯ãã€ã³ã°ã©ã³ãã§Covid-19ã¯ã¯ãã³ãæ¥çš®ãã246人ã«1人ããCovid-19ã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«æ»äº¡ããŠããããšãæããã«ããŸããã
ONS 'Deaths by vaccination status, England' ããŒã¿ã»ããã®è¡š9ã«ã¯ããç»é²ããããã¹ãŠã®æ»äº¡ãã¯ã¯ãã³æ¥çš®åŸäœé±éã§æ»äº¡ãããã«ãã£ãŠã°ã«ãŒãåããå šæéæ°ïŒCOVID-19ãå«ãæ»äº¡ãšCOVID-19ãå«ãŸãªãæ»äº¡ã«ã€ããŠã2021幎1æ1æ¥ãã2022幎5æ31æ¥ãŸã§ã«èµ·ããæ»äº¡ãã€ã³ã°ã©ã³ããã®æ°åãèšèŒãããŠããŸãã
ãã¡ãã¯ãOffice for National Statisticsã®ããŒã¿ã»ããã«ããã2021幎1æ1æ¥ãã2022幎3æ31æ¥ãŸã§ã®ã€ã³ã°ã©ã³ãã§ã®Covid-19ã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã®æ»äº¡æ°ã瀺ããã°ã©ãã§ãïœã

21幎1æ1æ¥ãã2022幎5æ31æ¥ã®éã«ãã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«Covid-19ã§æ»äº¡ãã人ã¯åèš14,103人ãã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«ä»ã®åå ã§æ»äº¡ãã人ã¯åèš166,556人ã§ããã
ã€ãŸããã€ã³ã°ã©ã³ãã§ã¯ã2021幎1æãã2022幎5æã®éã«ãå šéšã§180,659人ãCovid-19ã®ã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«æ»äº¡ããŠããããšã«ãªããŸãã
以äžã®è¡šã¯ãè±åœä¿å¥å®å šåºã®ç¬¬27é±ãWeekly national Influenza and COVID-19 surveillance reportãã®65ããŒãžããåŒçšããã€ã³ã°ã©ã³ãã«ããã幎霢å¥ã®ã¯ã¯ãã³æ¥çš®çã瀺ããŠããŸã -ã

UKHAã®çºè¡šã«ãããšã2022幎7æ3æ¥çŸåšã1åæ¥çš®ãã人ã¯4448äžäººã2åæ¥çš®ãã人ã¯4180äžäººã3åæ¥çš®ãã人ã¯3290äžäººãšãªã£ãŠããŸãã
ãããã£ãŠãåçŽèšç®ã§ãã€ã³ã°ã©ã³ãã§ã¯246人ã«1人ãCovid-19ã¯ã¯ãã³æ¥çš®åŸ60æ¥ä»¥å ã«æ»äº¡ããŠããããšãããããŸãã
44,480,115ïŒæ¥çš®è ïŒÃ·180,659ïŒæ»äº¡è ïŒïŒ246ïŒæ¥çš®è 246人ã«1人æ»äº¡
åºå žFïŒCOVID-19ã¯ã¯ãã³ã¯ãä»ã®ãã¹ãŠã®ã¯ã¯ãã³ã®åèšãããå°ãªããšã7,402ïŒ èŽåœçã§ãããšããè¡æçãªãã®ã§ããã
è±åœã®å»è¬åèŠå¶æ©é¢ã¯ã19ã¶æã®éã«ã³ããã-19ã¯ã¯ãã³ããéå»21幎éã«å©çšå¯èœãªä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãåããããã®ã®å°ãªããšã5.5åã®æ»äº¡ãåŒãèµ·ãããããšã確èªããŸãããã€ãŸããã³ããã-19泚å°ã¯ãè±åœã§å ¥æå¯èœãªä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãšæ¯èŒããŠã7,402%ãšããè¡æçãªèŽæ»çã瀺ããŠããããšã«ãªãã
å»è¬åã»ãã«ã¹ã±ã¢è£œåèŠå¶åºïŒMHRAïŒã¯ãæ å ±å ¬éè«æ±ïŒFOIïŒã«å¯ŸããŠã2001幎1æ1æ¥ãã2021幎8æ25æ¥ãŸã§ã®20幎8ã¶æã®éã«ãèŽåœçãªçµæã䌎ããã¹ãŠã®ã¯ã¯ãã³ïŒã³ããã19泚å°ãé€ãïŒã«å¯Ÿããå¯äœçšã®å ±åãåèš404ä»¶åããŠããããšã確èªããŸããã

ãŸããMHRAã¯å¥éãé±åã€ãšããŒã«ãŒãã®å ±åæŠèŠã§ã2021幎1æãã2022幎7æãŸã§ã®19ã«æéã«ãèŽåœçãªè»¢åž°ã«é¢é£ããã³ãã19泚å°å€ã®å¯äœçšãç·èš2213ä»¶åãåã£ãããšã確èªããŠãã--ã

ã€ãŸãã2001幎以æ¥ãããã19ã¶æã®éã«ãã³ãã19ã¯ã¯ãã³ã«ããæ»äº¡è æ°ã¯ãä»ã®ãã¹ãŠã®ã¯ã¯ãã³ã«ããæ»äº¡è æ°ã®5.5åã§ããããšãå ¬åŒã«ç€ºãããã®ã§ããã

20幎8ã¶æãšããæéã¯ãCovid-19ã¯ã¯ãã³ãå±éããã19ã¶æã®æéããã13.7åé·ãæéã§ãã
ãããã£ãŠã19ã¶æãšããåãæéã«ä»ã®ãã¹ãŠã®ã¯ã¯ãã³ãåãããŠå ±åãããæ»äº¡è æ°ã¯29.5人ã«çžåœããŸãã
ã€ãŸããã³ããã-19泚å°ã¯ãè±åœã§å ¥æå¯èœãªä»ã®ãã¹ãŠã®ã¯ã¯ãã³ããã7,402%ãèŽåœçã§ãããšããè¡æçãªäºå®ã蚌æããŠããã®ã§ãã

åºå žGïŒCOVIDã¯ã¯ãã³å±é以éãç«¶æè ã®æ»äº¡ãäºæ³ã®1700ïŒ å¢ã«
1966幎ãã2004幎ã®éã«å ¬åŒã«èšé²ãããã¢ã¹ãªãŒãã®å¹Žéæ»äº¡è æ°ãšæ¯èŒããŠã2021幎ã«å ¥ã£ãŠããæ»äº¡ããã¢ã¹ãªãŒãã®æ°ã¯é£èºçã«å¢å ããŠããŸãã
2021幎1æãã2022幎4æãŸã§ã®æå¹³åæ»äº¡è æ°ã¯ã1966幎ãã2004幎ãŸã§ã®æå¹³åæ»äº¡è æ°ã®1,700ïŒ ã§ããããŸã§ã®2022幎ã®åŸåã§ã¯ãæ»äº¡è æ°ã®å¢å ãç¶ãã°4,120ïŒ ã«ãŸã§å¢å ãã2022幎3æã®æ»äº¡è æ°ã ãã§ããããŸã§ã®å¹Žå¹³åã®3åã«ãªãå¯èœæ§ãããã»ã©ã§ãã
2006幎ã«çºè¡šãããã¹ã€ã¹ã®ããŒã¶ã³ã倧åŠç é¢å°å 埪ç°åšç§ã®ç§åŠçç ç©¶ã«ãããšã1966幎ãã2004幎ã®éã«35æ³ä»¥äžã®ã¹ããŒãéžæã®çªç¶æ»ã¯1,101ä»¶ã«äžããŸããã
ããŠãGoodSciencing.comããŒã ã®ãããã§ãæåã®ã³ãã19泚å°ãäžè¬åžæ°ã«æäžããã1ã«æåŸã®2021幎1æä»¥éã«åãããããã³/ãŸãã¯æ»äº¡ããã¢ã¹ãªãŒãã®å æ¬çãªãªã¹ããåºæ¥äžãããŸããã
ãã®ãããªé·ããªã¹ãã§ããããããã®èšäºã«ã¯æ²èŒããŠããŸããã®ã§ããã®å šãªã¹ãã¯ãã¡ãããã¢ã¯ã»ã¹ã§ããŸãã
以äžã®ã°ã©ãã¯ã2021幎1æãã2022幎4æã®éã«èšé²ãããã¢ã¹ãªãŒãã®åãããæ»ãã ãããæ°ã瀺ããŠãããäžèšã®ãªã³ã¯å ã®ãªã¹ãã®æäŸã§ãã

2021幎1æä»¥éã«å¢å ããŠããããšã¯ééããªãããåé¡ã¯ããããéåžžã®ããšã§ãããäºæ³ãããããšãªã®ãã©ããã§ããã
1æ21æ¥ãã4æ22æ¥ãŸã§ã®éã«ãåèš673人ã®ã¢ã¹ãªãŒããæ»äº¡ããããšãç¥ãããŠããããããããã®æ°ã¯ãã£ãšå€ãå¯èœæ§ãããã1966幎ãã2004幎ã«ãããŠã®æ»äº¡è æ°ããã428人å°ãªãããã ããããããã®éãã¯ã1,101äººã®æ»ã39幎éã«èµ·ãã£ãã®ã«å¯Ÿããæè¿ã®673äººã®æ»ã¯16ã¶æéã«èµ·ãã£ããšããããšã§ãã

1966幎ãã2004幎ãŸã§ã®å¹Žéå¹³åæ»è æ°ã¯28人ã«çžåœããã2022幎1æã¯ãã®éå»ã®å¹Žå¹³åã®3åã2022幎3æã¯3åã®ã¢ã¹ãªãŒãæ»è ãåºãŠãããã€ãŸããããã¯æããã«åé¡ã匷ã瀺åããŠããã
2021幎ã®åèšã¯394äººã®æ»äº¡ã«çžåœãã1966幎ãã2004幎ã®å¹Žéå¹³åã®14åã§ããã2022幎1æãã4æãŸã§ã®4ã¶æéã®åèšã§ã¯279äººã®æ»äº¡ã«çžåœãã1966幎ãã2004幎ã®å¹Žéå¹³åã®9.96åã§ããã
ãããã66幎ãã04幎ã®å¹Žå¹³åã3ã§å²ã£ãŠ2022幎ã®ãããŸã§ã®4ã«æåã®æ»è æ°ã«çžåœããããšã9.3人ãšãªããã€ãŸãå®è³ªçã«ã¯ã2022幎ã®ãããŸã§ã®æ»äº¡è æ°ã¯ãäºæ³ãããæ»äº¡è æ°ã®10åã§ããã
次ã®ã°ã©ãã¯ãèšé²ãããã¹ããŒãéžæã®æ»äº¡è æ°ã®æå¹³åã瀺ãããã®ã§ãã
1966幎ãã2004幎ãŸã§ã®å¹Žéå¹³åæ»äº¡è æ°ã¯28人ã«çžåœããã2022幎1æã¯ãã®å¹Žå¹³åã®3åã2022幎3æã3åã®ã¢ã¹ãªãŒããæ»äº¡ããŠããŸããã€ãŸããããã¯æããã«åé¡ã匷ã瀺åããŠããã
2021幎ã®åèšã¯394äººã®æ»äº¡ã«çžåœãã1966幎ãã2004幎ã®å¹Žéå¹³åã®14åã§ããã2022幎1æãã4æãŸã§ã®4ã¶æéã®åèšã§ã¯279äººã®æ»äº¡ã«çžåœãã1966幎ãã2004幎ã®å¹Žéå¹³åã®9.96åã§ããã
ãããã66幎ãã04幎ã®å¹Žå¹³åã3ã§å²ã£ãŠ2022幎ã®ãããŸã§ã®4ã«æåã®æ»è æ°ã«çžåœããããšã9.3人ãšãªããã€ãŸãå®è³ªçã«ã¯ã2022幎ã®ãããŸã§ã®æ»äº¡è æ°ã¯ãäºæ³ãããæ»äº¡è æ°ã®10åã§ããã
次ã®ã°ã©ãã¯ãã¢ã¹ãªãŒãã®æ»äº¡èšé²æ°ã®æå¹³åã瀺ãããã®ã§ãã

1966幎ãã2004幎ãŸã§ã®æå¹³åæ»äº¡è æ°ã¯2.35人ã§ããããããã2021幎1æãã2022幎4æãŸã§ã®æå¹³åã¯42ã«çžåœãããããã¯1,696ïŒ ã®å¢å ã§ãã
ç· ãããã: ããŒã¿ã¯åãã€ããªã
ã³ãã19ã®æ³šå°ãæ¯é±äœåäžäººãã®äººã ãæ®ºããŠããããšã蚌æãã蚌æ ããäžã®äžã«ã¯ããããããã®ã ãäŸãã°ãè±åœæ¿åºã¯ãå®å šãªã¯ã¯ãã³æ¥çš®ãåããè¥å¹Žå±€ããã¯ã¯ãã³æªæ¥çš®ã®è¥å¹Žå±€ãããæ»äº¡ãã確çã92ïŒ é«ãããšã確èªããŠããïŒãã¡ããåç §ïŒã
ãŸããCOVIDã¯ã¯ãã³ãæ¥çš®ããåã©ãã¯ãæ¥çš®ããŠããªãåã©ãã«æ¯ã¹ãŠãäœããã®åå ã§æ»äº¡ããå¯èœæ§ãå°ãªããšã4423ïŒ é«ããCOVID-19ã§æ»äº¡ããå¯èœæ§ã13633ïŒ é«ãããšã確èªããŠããïŒãã¡ããåç §ïŒ
ããããæãäžå©ãªèšŒæ ã¯4ã€ã®åçŽãªäºå®ã§ããã
äºå®ãã®1ïŒå»çèŠå¶åœå±ã¯ã³ãã19ã®ã¯ã¯ãã³ãå¿èã«ãã¡ãŒãžãäžããããšãèªããããåŸãªããªã£ãã
äºå®ãã®2ïŒèšé²çãªæ°ã®äººã ããå¿èã«åœ±é¿ãäžããçç¶ã®ããã«ææ¥è»ãèŠè«ããŠããã
äºå®ãã®3ïŒäžçäžã§æ¯é±äœåäžäººãã®éå°æ»äº¡ãèšé²ãããŠããããã³ããã19ã«èµ·å ãããšèšããã®ã¯ããå°æ°ã§ããã
äºå®ãã®4ïŒå¹Žéœ¢æšæºåæ»äº¡çã¯ããã¹ãŠã®å¹Žéœ¢å±€ã§ã¯ã¯ãã³æªæ¥çš®è ã®éã§æãäœãã
ããã¯æ ¹æ ã®ãªã䞻匵ã§ã¯ãªãããããã¯æ¿åºã®å ¬åŒçµ±èšã§ãããæ¿åºã®å ¬åŒå ±åæžã«èšèŒãããŠãããã®ã§ããã
ãããã£ãŠãæ¿åºã®å ¬åŒå ±åæžã¯ãã³ãã19ã®ã¯ã¯ãã³æ¥çš®ã«ãã£ãŠæ¯é±äœåäžäººãã®äººã ã亡ããªã£ãŠããããšãçãäœå°ããªã蚌æããŠããã®ã§ããã